A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study was to evaluate the safety and tolerability of nasal glucagon
(NG). The study drug was delivered into the participant's nostril (intranasally) or was given
as an injection just under the skin (subcutaneously) once in each of four study periods. The
study lasted about 23 days for each participant.